コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 s of resolution and submit the methods to a "stress test".
2 he patients remained asymptomatic during the stress test.
3 e ranges of these values during the exercise stress test.
4 cular events than those who attained maximal stress test.
5 effective than a pathway that mandates a CMR stress test.
6 fting, congestive heart failure, or abnormal stress test.
7 months, and 12 to 13 months after the prior stress test.
8 d greater glycolytic flux in a bioenergetics stress test.
9 ive results occurred in 6% of CTA and 10% of stress tests.
10 erica, MA, USA) during specifically designed stress tests.
11 1.05-1.45) were also more likely to receive stress tests.
12 sured at baseline and following the 3 mental stress tests.
13 who had clinical indications for cardiac MRI stress tests.
14 y during spontaneous respiration and dynamic stress tests.
15 ars of PCI, with one third undergoing repeat stress tests.
16 n during spontaneous respiration and dynamic stress tests.
17 rated and can be safely used for cardiac MRI stress tests.
18 n during spontaneous respiration and dynamic stress tests.
19 le urine sniffing, and chronic unpredictable stress tests.
20 ithout a CAD history presenting for exercise stress tests.
21 nts, and patients undergoing pharmacological stress testing.
22 chest pain evaluation, and repeat imaging or stress testing.
23 identify predictors of preoperative cardiac stress testing.
24 of patients were asymptomatic at the time of stress testing.
25 ients who underwent unnecessary preoperative stress testing.
26 inducible myocardial ischemia during cardiac stress testing.
27 % CI: 1.03-1.32) were positive predictors of stress testing.
28 d the rate of observation unit admission for stress testing.
29 ferences were driving the decision to obtain stress testing.
30 ary end point was major adverse event during stress testing.
31 dergo observation unit admission and cardiac stress testing.
32 related spending than patients who underwent stress testing.
33 c, often requiring prolonged observation and stress testing.
34 tential effectiveness of novel multimodality stress testing.
35 patients had ventricular ectopy on exercise stress testing.
36 pharmacologic vasodilators used for cardiac stress testing.
37 iness in the selection of shock scenarios in stress testing.
38 t repeat revascularization within 60 days of stress testing.
39 Spearman rank correlation coefficient during stress tests (0.89) and after stress relaxation (0.86).
40 .2% required echocardiography, 1.7% exercise stress test, 1.2% Holter, 1.2% cardiac magnetic resonanc
41 e of three different conditions prior to the stress test: 1) relaxing music ('Miserere', Allegri) (RM
42 abetic patients (CTA: 1.4% [50 of 3,564] vs. stress testing: 1.3% [45 of 3,494]; adjusted hazard rati
45 al stress testing (CTA: 1.1% [10 of 936] vs. stress testing: 2.6% [25 of 972]; adjusted hazard ratio:
46 with no cardiac indications for preoperative stress testing, 3.75% (N = 2803) received stress testing
47 aphy angiography [CTA], 52% female; 4,466 to stress testing, 53% female), we assessed the relationshi
48 y to be admitted to the observation unit for stress testing (58% versus 77%; absolute difference, 19%
49 na (53.8%), low-risk ischemia on noninvasive stress testing (71.6%), or suboptimal (</=1 medication)
50 l patients were more likely to have abnormal stress tests (90% versus 43%; P=0.01) and had more exten
52 rding to both objective criteria (a negative stress test, a negative pad test, and no retreatment) an
53 ts possibly safe for early discharge without stress testing, a strategy that could have tremendous he
54 al tachycardia in one third of GWI subjects (Stress Test Activated Reversible Tachycardia, START).
55 were exposed to a standardized psychosocial stress test after having been randomly assigned to one o
56 tudy was to determine the pattern of cardiac stress testing after coronary revascularization in commu
57 ensus as to the appropriate role of elective stress testing after coronary revascularization, more th
58 ittle is known about the patterns of cardiac stress testing after PCI in the single-payer Canadian he
65 ciation between physician billing and use of stress testing, after adjusting for patient and other ph
67 ive: To determine trends in rates of cardiac stress testing among a large and diverse cohort of comme
70 also underwent a standard laboratory social stress test and provided saliva samples for cortisol ass
74 evel variation in risk-standardized rates of stress testing and the association with 1-year mortality
75 ate risk of coronary heart disease underwent stress testing and those with a positive test were treat
76 ding by indication (driven by varying use of stress testing and thresholds for invasive angiography),
77 ects (n=7) during 15-minute cardiac exercise stress tests and 30 minutes after stress relaxation in 3
78 ructed and validated in vitro by temperature stress tests and in vivo by evaluation of attenuation in
79 iac magnetic resonance (including dobutamine stress testing), and the Short Form-36 questionnaire.
80 these inappropriate patients had no previous stress test, and approximately 90% of inappropriate pati
83 ognitive performance during the Trier Social Stress Test, and used self-report questionnaires to asse
84 ntation, myocardial perfusion on provocative stress testing, and management of children with anomalou
85 gesting opportunities to optimize the use of stress testing are still present in integrated healthcar
86 it is not known whether declines in cardiac stress testing are universal or are confined to certain
88 ed HEART score </=3, early discharge without stress testing as compared with transfer to an observati
89 cardiologists rated 256 (64%) of 400 nuclear stress tests as appropriate, 68 (18%) as uncertain, 55 (
92 men, displacement behaviour during a social stress test attenuated the relationship between anxiety
95 consecutive patients who underwent exercise stress testing before and after completion of a phase 2
96 cal risk factors) should not undergo cardiac stress testing before elective noncardiac, nonvascular s
97 objective was to evaluate whether receipt of stress testing before elective PCI predicts mortality.
98 es advise testing for ischemia, such as with stress testing, before elective percutaneous coronary in
99 d/anxiety on the presence of ischemia during stress testing by CAD history in a stratified analyses,
101 ry electrocardiographic monitoring, exercise stress testing, cardiac CT, heart and brain MRI, serial
103 pothesized that listening to RM prior to the stress test, compared to SW or R would result in a decre
104 risk scores with an echocardiogram, exercise stress test, computerized tomographic coronary angiogram
105 ce and ultrahigh stability under accelerated stress test conditions and can be considered as a promis
106 electron microscopy analysis, mitochondrial stress testing, confocal live imaging for mitochondrial
108 ms, but neither risk factors nor noninvasive stress tests, contributed to predicting a pathological t
109 ) and noninvasive (such as blood biomarkers, stress testing, CT and nuclear scanning), permit assessm
110 risk of CV death/MI compared with functional stress testing (CTA: 1.1% [10 of 936] vs. stress testing
111 iduals aged 55 to 64 years, rates of cardiac stress testing decreased by 12.3% from 2005 (7894 tests;
112 The hospital-level risk-standardized rate of stress testing differed significantly from the average a
113 ctrocardiography, Holter recording, exercise stress test, echocardiography, and/or cardiac magnetic r
114 ary cortisol response to standardized mental stress tests (exposure) and hs-cTnT plasma concentration
115 rt rate (HR) reduction following an exercise stress test (ExStrT), an easily quantifiable marker of v
118 escribed in implementing a new multimodality stress test for accurate correlation of complementary fu
123 here was a 3.0% increase in rates of cardiac stress testing from 2005 (3486 tests; 95% CI, 3458-3514)
125 n early AKI, urine output after a furosemide stress test (FST), which involves intravenous administra
126 ndividuals in UKB who underwent the exercise stress test had a cardiovascular event, and TMR(rec) was
128 ate, 56.7% were asymptomatic/had no previous stress test/had low or intermediate global coronary arte
132 to test the hypotheses that ischemia during stress testing has prognostic value and identifies those
133 ter a period of rapid growth, use of cardiac stress testing has recently decreased among Medicare ben
134 Rs were largely nonoverlapping, all types of stress tested here resulted in desumoylation of subunits
135 higher risk of mortality than those in high stress test/high PCI regions (adjusted hazard ratio, 1.1
137 test/high PCI, low stress test/low PCI, low stress test/high PCI, and high stress/low PCI regions.
138 regions and categorized into 4 groups: high stress test/high PCI, low stress test/low PCI, low stres
144 sive review of the current available data on stress testing in aortic stenosis and subsequently summa
146 s known regarding the use of routine cardiac stress testing in coronary artery bypass grafting or per
148 angiography (CTA) is superior to functional stress testing in reducing adverse cardiovascular (CV) o
149 al longitudinal strain (LV-GLS) and exercise stress testing in risk stratification of patients with s
150 n contrast to declines in the use of cardiac stress testing in some health care systems, we observed
151 tic information derived from anatomic versus stress testing in stable men and women with suspected co
153 In the VA, nearly 40% of patients underwent stress testing in the 2 years after PCI, which is a thir
155 without inducible ischemia during dobutamine stress testing in whom one might otherwise assume a favo
156 normal heart rate (HR) response to exercise stress testing in women is poorly understood, given that
157 AT) at baseline and following 3 acute mental stress tests in female patients with ABS (n = 12, at lea
159 at rest and at peak of low-dose Dipyridamole stress test, in the assessment of significant coronary a
160 iduals aged 25 to 34 years, rates of cardiac stress testing increased 59.1% from 2005 (543 tests; 95%
167 a robust predictor of clinical outcomes, and stress testing is used in current practice paradigms to
169 incidental findings, and when performed with stress testing, its incremental cost-effectiveness ratio
171 nto 4 groups: high stress test/high PCI, low stress test/low PCI, low stress test/high PCI, and high
173 ere consistent, suggesting that the in vitro stress test may be used as a method to predict the liabi
175 t that observed trends in the use of cardiac stress testing may have been driven more by unique chara
181 visit involving exposure to the Trier Social Stress Test modified to maximize between-sex differences
183 recovery after exposure to the Trier Social Stress Test (n = 444), and (c) cortisol concentration in
185 aging test (n=60) or (2) a provider-selected stress test (n=60: stress echo [62%], CMR [32%], cardiac
186 n of Chest Pain) patients were randomized to stress testing (n=4533) or computed tomographic angiogra
188 Of the tests performed for ischemic CAD, stress testing (nuclear stress testing or stress echocar
189 lihood of black patients receiving a cardiac stress test (odds ratio, 0.91 [95% CI, 0.69 to 1.21]) th
191 disease, spontaneous respiration and dynamic stress tests on pulmonary artery wave propagation and re
192 H patients who underwent a radionuclide (RN) stress test or a dobutamine stress echocardiogram (DSE).
193 ts underwent pharmacological radionucleotide stress test or dobutamine stress echocardiography before
194 ment options (observation unit admission and stress testing or 24-72 hours outpatient follow-up).
195 primary outcome, objective cardiac testing (stress testing or angiography), and secondary outcomes,
196 ally intermediate stenoses in the absence of stress testing or in the presence of discordant stress t
197 utcomes, but performing CCTA-with or without stress testing or performing stress single-photon emissi
198 ed for ischemic CAD, stress testing (nuclear stress testing or stress echocardiography) was performed
206 ures: Age- and sex-adjusted rates of cardiac stress tests per calendar quarter (reported as number of
207 g PCI at 55 VA hospitals, 2239 (21.8%) had a stress test performed within 1 year of PCI and 3902 (37.
209 ditis protocol (group A), 10 patients with a stress-testing protocol (group B), and six patients with
216 ant heart disease and medical comorbidities, stress testing represents a reasonable strategy to help
217 ikely to have a positive CTA than a positive stress test result (16% vs. 14%; adjusted odds ratio: 1.
218 0% stenosis) was less likely than a positive stress test result (8% vs. 12%; adjusted odds ratio: 0.6
219 h subsequent clinical events than a positive stress test result (CTA-adjusted hazard ratio of 5.86 vs
221 h subsequent clinical events than a positive stress test result in men, although this difference was
223 ly than those who did not to have a positive stress test result, but angina was similar in both group
225 onducted to evaluate the correlation between stress test results and coronary computed tomography ang
226 cardiac outcomes between those with negative stress test results and those with positive stress test
227 ar after transplant, the group with positive stress test results experienced more cardiac events (34.
228 Demographics, risk factors, symptoms, and stress test results were correlated with obstructive CAD
236 s most suggestive of ACS were prior abnormal stress test (specificity, 96%; LR, 3.1 [95% CI, 2.0-4.7]
238 hoton emission computed tomographic exercise stress test (standard Bruce Protocol) and underwent a ps
239 ronary heart disease, regardless of exercise stress testing status, underwent a battery of 3 mental s
241 hown that a cardiac magnetic resonance (CMR) stress test strategy implemented in an observation unit
242 among lower-risk patients if a mandatory CMR stress test strategy was more effective than a physician
243 lthy male donors undergoing the Trier Social Stress Test (stress) and bicycle ergometer training (spo
245 pulmonary regurgitant fraction, on exercise stress test the 22q11.2DS had significantly lower percen
246 s can undergo a carefully monitored exercise stress test to confirm both their asymptomatic status an
247 s gap in knowledge, we developed a cartilage stress test to measure the in vivo strain response of he
248 have stable ischemic heart disease, cardiac stress testing to assess the risk for death or myocardia
249 y disease and moderate or severe ischemia on stress testing to be treated with an initial invasive st
253 y statins are available, noninvasive cardiac stress testing to target preventive medications is not c
256 o an experimental stressor, the Trier Social Stress Test (TSST), in 208 offspring of parents with moo
259 Physician decision making about cardiac stress test use does not seem to contribute to racial/et
260 nfluence of Medicare eligibility on rates of stress testing use in the VA, we excluded Medicare eligi
262 ronary artery disease underwent acute mental stress testing using a series of standardized speech/ari
263 ronary artery disease underwent acute mental stress testing using a series of standardized speech/ari
264 icine interns) classified individual nuclear stress tests using the 2009 Appropriate Use Criteria.
265 satisfaction, rates of positive provocative stress tests, voiding dysfunction, or adverse events.
267 of U.S. ambulatory visits in which a cardiac stress test was ordered or performed increased from 28 p
269 red with transfer to an observation unit for stress testing was associated with significant reduction
272 % of inappropriate patients with no previous stress test were asymptomatic with low or intermediate g
276 Population-based rates of elective PCI and stress testing were calculated for 306 hospital referral
280 gh-throughput screening (HTS) campaigns, two stress tests were performed regarding ion suppression an
282 xes or ventricular tachycardia upon exercise stress tests when sinus rate exceeded 99+/-17 beats per
283 ry artery disease risk, 36.0% had a previous stress test with low-risk findings and no symptoms, and
284 3+/-9, 76% male, 29% black) underwent mental stress testing with a standardized public speaking stres
286 rred for invasive coronary angiography after stress testing with myocardial perfusion positron emissi
287 rred for invasive coronary angiography after stress testing with myocardial perfusion positron emissi
291 ith PCI, 67 442 (59.8%) underwent at least 1 stress test, with 38 267 (34.0%) undergoing repeat stres
294 e appropriate use criteria considers cardiac stress testing within 2 years after percutaneous coronar
295 METHODS AND Frequency and timing of cardiac stress testing within 2 years of PCI performed between A
296 re than half of all patients undergo cardiac stress testing within 2 years of PCI, with one third und
297 ive incidence of nuclear or echocardiography stress testing within 30 days of the index cardiac-relat
298 Incidence of nuclear and echocardiographic stress tests within 30 days of an index cardiac-related